GOLPH3 and glioma: The in vivo silencing of GOLPH3, in a combinatorial anti-tumor therapy, by using GOLPH3 siRNA and Gefitinib both conjugated to nanoparticles, inhibited EGFR signalling and glioma growth in the mouse model (Ye et al., 2019).